Prof. Dr. Hurrem BODUR

1. Epidemiological characteristics and risk factors associated with bacteremia caused by intrinsically colistin-resistant gram-negative microorganisms: a case–control study

Büyüktarakçı Karali C., BAŞTUĞ A., SERTÇELİK A., BODUR H.

BMC Infectious Diseases , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach

DİRİCAN E., Bal T., Onlen Y., Sarigul F., User U., SARI N. D., et al.

Journal of Clinical Laboratory Analysis , cilt.39, sa.12, 2025 (SCI-Expanded, Scopus)

3. Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy?

ALTUNSOY A., COŞER Ş., Kemirtlek N., Aykanat I. C., Balci M., BODUR H., et al.

Journal of Infection in Developing Countries , cilt.18, sa.4, ss.595-599, 2024 (SCI-Expanded, Scopus)

4. Candidemia in critically ill COVID-19 patients: Risk factors and impact on mortality

KAZANCIOĞLU S., BODUR H., MUMCUOĞLU İ., BAŞTUĞ A., Ozbay B. O., Aydos O., et al.

Heliyon , cilt.10, sa.6, 2024 (SCI-Expanded, Scopus)

5. Concordance and generalization of an AI algorithm with real-world clinical data in the pre-omicron and omicron era

YILMAZ G., Sezer S., BAŞTUĞ A., Singh V., Gopalan R., Aydos O., et al.

Heliyon , cilt.10, sa.3, 2024 (SCI-Expanded, Scopus)

6. Rare Conditions of Candidemia: Risk Factors and Outcomes for Mixed Candidemia and Late Recurrent Candidemia Nadir Kandidemi Durumları: Mikst Kandidemi ve Geç Tekrarlayan Kandidemi için Risk Faktörleri ve Sonuçları

Özbay B. O., BAŞTUĞ A., Aydos Ö., Kemirtlek N., GÖKÇINAR D., DİNÇ B., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.13, 2024 (ESCI, Scopus, TRDizin)

7. Plasma protein biomarkers reflective of the host response in patients developing Intensive Care Unit-acquired pneumonia

van Engelen T. S. R., Reijnders T. D. Y., Paling F. P., Bonten M. J. M., Malhotra-Kumar S., Kluytmans J. A. J. W., et al.

Critical Care , cilt.27, sa.1, 2023 (SCI-Expanded, Scopus)

8. The usefulness of hematological parameters and cerebrospinal fluid indexes in the differential diagnosis of acute bacterial from viral meningitis

KAZANCIOĞLU S., BAŞTUĞ A., Ozbay B. O., Tezcan H., Buyuktarakci C., Akbay A., et al.

Diagnostic Microbiology and Infectious Disease , cilt.107, sa.1, 2023 (SCI-Expanded, Scopus)

9. An investigation of clinical characteristics and antimicrobial agent susceptibility patterns in clinical Comamonas testosteroni isolates: An increasingly prevalent nosocomial pathogen

Ozbay B. O., Aypak A., BAŞTUĞ A., Aydos Ö., MUMCUOĞLU İ., Büyükberber S. G., et al.

Infectious Diseases Now , cilt.53, sa.2, 2023 (SCI-Expanded, Scopus)

10. Safety, Efficacy and Direct/Indirect Cost Analysis of an Outpatient Antimicrobial Therapy Unit: A Prospective Cohort Study from Turkey

Özbay B. O., BAŞTUĞ A., Öksüz E., BODUR H.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.12, 2023 (ESCI, Scopus, TRDizin)

11. The Prevalence of Sexually Transmitted Infections and Related Factors Among People Living with HIV in Turkey Türkiye’de HIV ile Yaşayan Bireylerde Cinsel Yolla Bulaşan Enfeksiyonların Sıklığı ve Risk Faktörleri

Taşpinar Şen E., BAŞTUĞ A., Aypak A., BODUR H.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.12, 2023 (ESCI, Scopus, TRDizin)

12. Evaluation of the models generated from clinical features and deep learning-based segmentations: Can thoracic CT on admission help us to predict hospitalized COVID-19 patients who will require intensive care?

Gülbay M., BAŞTUĞ A., Özkan E., Öztürk B. Y., Mendi B. A. R., BODUR H.

BMC Medical Imaging , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

13. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey

Yildirim F. S., User U., SARI N. D., Kurtaran B., Önlen Y., Senates E., et al.

Turkish Journal of Gastroenterology , cilt.33, sa.11, ss.971-978, 2022 (SCI-Expanded, Scopus, TRDizin)

14. Prognostic Value of Hemogram-Derived Ratios in Patients with Crimean-Congo Hemorrhagic Fever

KAZANCIOĞLU S., BAŞTUĞ A., Ozdemir B., AKINCI E., BODUR H.

Vector-Borne and Zoonotic Diseases , cilt.22, sa.9, ss.465-471, 2022 (SCI-Expanded, Scopus)

15. Eggerthia catenaformis-related peritonitis in a patient with peritoneal dialysis

Özbay B. O., BAŞTUĞ A., Köksal Cevher Ş., Yenigün E. C., MUMCUOĞLU İ., BODUR H.

Anaerobe , cilt.75, 2022 (SCI-Expanded, Scopus)

16. The changing dynamics of neutralizing antibody response within 10 months of SARS-CoV-2 infections

BAŞTUĞ A., BODUR H., Aydos O., KORKULU N., Oksuz E., ÖZKUL A.

Journal of Medical Virology , cilt.94, sa.5, ss.1983-1989, 2022 (SCI-Expanded, Scopus)

17. PARA-INFECTIOUS GUILLAIN BARRE SYNDROME IN A PATIENT DIAGNOSED WITH COVID-19

BAŞTUĞ A., BEKTAŞ H., Buyuktarakci C., BODUR H.

Ankara Medical Journal , cilt.22, sa.1, ss.167-171, 2022 (Scopus, TRDizin)

18. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

MERT A., VAHABOĞLU H., Arslan F., BATIREL A., Saraçoğlu K. T., BAŞTUĞ A., et al.

Rheumatology International , cilt.42, sa.3, ss.457-467, 2022 (SCI-Expanded, Scopus)

19. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia

KAZANCIOĞLU S., BAŞTUĞ A., KAYAASLAN B., MUTLU N. M., Calci E., TURHAN T., et al.

Journal of Infection in Developing Countries , cilt.16, sa.2, ss.362-368, 2022 (SCI-Expanded, Scopus)

20. Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A single-center cohort study

BAŞTUĞ S., Çavdarlı B., BAŞTUĞ A., ŞENCAN İ., Tunçez E., Çakır E. Y., et al.

Anatolian Journal of Cardiology , cilt.26, sa.2, ss.133-140, 2022 (SCI-Expanded, Scopus, TRDizin)

21. Neutralizing antibody response and associated factors in Coronavirus-19 disease (COVID-19) up to one month

BAŞTUĞ A., BODUR H., ŞEKER U. Ö. Ş., KORKULU N., Aydos O., Kehribar E. S., et al.

Turkish Journal of Biochemistry , cilt.47, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus, TRDizin)

22. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study

KÜÇÜKŞAHİN O., ERDEN A., Karakaş Ö., Güven S. C., Armağan B., Şahiner E. S., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.5, ss.1486-1494, 2022 (SCI-Expanded, Scopus, TRDizin)

23. Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases

GÜNER H. R., KAYAASLAN B., HASANOĞLU İ., Aypak A., BODUR H., ATEŞ İ., et al.

BMC Infectious Diseases , cilt.21, sa.1, 2021 (SCI-Expanded, Scopus)

24. Predictive performance of CT for adverse outcomes among COVID-19 suspected patients: A two-center retrospective study

Baysal B., Dogan M. B., Gulbay M., Sorkun M., Koksal M., BAŞTUĞ A., et al.

Bosnian Journal of Basic Medical Sciences , cilt.21, sa.6, ss.738-744, 2021 (SCI-Expanded, Scopus)

25. SARS-CoV-2 Detection with de Novo-Designed Synthetic Riboregulators

Köksaldl İ. Ç., Köse S., Ahan R. E., Haclosmanoǧlu N., Şahin Kehribar E., Güngen M. A., et al.

Analytical Chemistry , cilt.93, sa.28, ss.9719-9727, 2021 (SCI-Expanded, Scopus)

26. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19

KAZANCIOĞLU S., Yilmaz F. M., BAŞTUĞ A., Sakalll A., Ozbay B. O., Buyuktarakci C., et al.

Viral Immunology , cilt.34, sa.5, ss.342-351, 2021 (SCI-Expanded, Scopus)

27. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective

BAŞTUĞ A., Oksuz E., KAZANCIOĞLU S., Malhan S., Ozbay B. O., BODUR H.

International Journal of Clinical Practice , cilt.75, sa.6, 2021 (SCI-Expanded, Scopus)

28. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent

BAŞTUĞ A., Aslaner H., Aybar Bilir Y., Kemirtlek N., Gursoy F. M., BAŞTUĞ S., et al.

Rheumatology International , cilt.41, sa.5, ss.993-1008, 2021 (SCI-Expanded, Scopus)

29. Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir

GÜNER H. R., HASANOĞLU İ., KAYAASLAN B., Aypak A., AKINCI E., BODUR H., et al.

Journal of Infection and Public Health , cilt.14, sa.3, ss.365-370, 2021 (SCI-Expanded, Scopus)

30. A CT radiomics analysis of COVID-19-related ground-glass opacities and consolidation: Is it valuable in a differential diagnosis with other atypical pneumonias?

Gülbay M., Özbay B. O., Mendi B. A. R., BAŞTUĞ A., BODUR H.

PLoS ONE , cilt.16, sa.3 March, 2021 (SCI-Expanded, Scopus)

31. Molecular characterization of human adenoviruses associated with respiratory infection in Turkey

BAŞTUĞ A., Altas A. B., Koc B. T., Bayrakdar F., Korukluoglu G., BODUR H., et al.

APMIS , cilt.129, sa.1, ss.23-31, 2021 (SCI-Expanded, Scopus)

32. Evaluation of in Vitro Synergistic Activities of Some Antibiotic Combinations Containing Colistin, Meropenem, Vancomycin, and Minocycline against Oxacillinase-48 Carbapenemase-producing Klebsiella pneumoniae Oksasilinaz-48 Karbapenemaz Üreten Klebsiella pneumoniae Izolatlarina Karşi Kolistin, Meropenem, Vankomisin ve Minosiklin Içeren Bazi Antibiyotik Kombinasyonlarinin in Vitro Sinerjistik Aktivitelerinin Deǧerlendirilmesi

SERTÇELİK A., Baran I., AKINCI E., KAZANCIOĞLU S., BODUR H.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, 2021 (ESCI, Scopus)

33. Platelet hyperreactivity related with covid- 19 disease severity

Tuncay M. E., BAŞTUĞ A., Erdogan S., KAZANCIOĞLU S., Yakisik E., ERDEM D., et al.

Ankara Medical Journal , cilt.23, sa.1, ss.386-397, 2021 (Scopus, TRDizin)

34. Assessment of galectin-1, galectin-3, and prostaglandin e2 levels in patients with covid-19

KAZANCIOĞLU S., Yilmaz F. M., BAŞTUĞ A., Ozbay B. O., Aydos O., Yücel Ç., et al.

Japanese Journal of Infectious Diseases , cilt.74, sa.6, ss.530-536, 2021 (SCI-Expanded, Scopus)

35. Analysis of videos about malaria on YouTube: Evaluation of the Turkish and English content Sıtma ile ilgili YouTube videolarının analizi: Türkçe ve İngilizce içeriklerin değerlendirilmesi

KAZANCIOĞLU S., BODUR H.

Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.78, sa.4, ss.467-476, 2021 (Scopus, TRDizin)

36. The role of haematological parameters in patients with COVID-19 and influenza virus infection

KAZANCIOĞLU S., BAŞTUĞ A., Ozbay B. O., Kemirtlek N., BODUR H.

Epidemiology and Infection , cilt.148, 2020 (SCI-Expanded, Scopus)

37. Clinical and laboratory features of COVID-19: Predictors of severe prognosis

BAŞTUĞ A., BODUR H., Erdogan S., GÖKÇINAR D., KAZANCIOĞLU S., Kosovali B. D., et al.

International Immunopharmacology , cilt.88, 2020 (SCI-Expanded, Scopus)

38. Virolactia in an Asymptomatic Mother with COVID-19

BAŞTUĞ A., Hanifehnezhad A., TAYMAN C., ÖZKUL A., Ozbay O., KAZANCIOĞLU S., et al.

Breastfeeding Medicine , cilt.15, sa.8, ss.488-491, 2020 (SCI-Expanded, Scopus)

39. Antibiotic usage in hospitalized patients: a one-day point prevalence study

Karabay O., Ince N., Aypak A., Guclu E., BODUR H.

Journal of Chemotherapy , cilt.32, sa.4, ss.188-192, 2020 (SCI-Expanded, Scopus)

40. Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant Acinetobacter baumannii Strains

SERTÇELİK A., Baran I., AKINCI E., MUMCUOĞLU İ., BODUR H.

Microbial Drug Resistance , cilt.26, sa.5, ss.429-433, 2020 (SCI-Expanded, Scopus)

41. A micro-elimination approach to addressing hepatitis C in Turkey

İDİLMAN R., Razavi H., Robbins-Scott S., Akarca U. S., Örmeci N., Kaymakoglu S., et al.

BMC Health Services Research , cilt.20, sa.1, 2020 (SCI-Expanded, Scopus)

42. Hemolysis and acute kidney injury following intravenous artesunate therapy in severe falciparum Malaria: A case report

Ozdemir B., ÖNGÜRÜ P., Taspinar E., BODUR H.

Southeast Asian Journal of Tropical Medicine and Public Health , cilt.50, sa.3, ss.428-432, 2019 (SCI-Expanded, Scopus)

43. Bovine herpesvirus type 4 (BoHV-4) vector delivering nucleocapsid protein of crimean-congo hemorrhagic fever virus induces comparable protective immunity against lethal challenge in IFNα/βγγR-/-/mice models

Farzani T. A., Földes K., Hanifehnezhad A., Ilce B. Y., BİLGE DAĞALP S., Khiabani N. A., et al.

Viruses , cilt.11, sa.3, 2019 (SCI-Expanded, Scopus)

44. Evaluation of epidemiological, clinical, and laboratory features and mortality of 144 HIV/AIDS cases in Turkey

Ozdemir B., Yetkin M. A., BAŞTUĞ A., But A., Aslaner H., AKINCI E., et al.

HIV Clinical Trials , cilt.19, sa.2, ss.69-74, 2018 (SCI-Expanded, Scopus)

45. Antibiotic consumption, resistance data, and prevention strategies Antibiyotik Tüketimi, Direnç Verileri ve Önlem Stratejileri

Karabay O., BAŞTUĞ A., ÖZTÜRK R., ŞENCAN İ., Aksoy M., Şi̇Mşek H., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.2018, sa.7, ss.7-35, 2018 (Scopus)

46. Evaluation of surgical site infections detected in a tertiary care hospital Üçüncü basamak bir hastanede tespit edilen cerrahi alan enfeksiyonlarinin değerlendirilmesi

Aslaner H., AKINCI E., But A., Kanyilmaz D., BAŞTUĞ A., Aypak A., et al.

Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.75, sa.3, ss.265-276, 2018 (Scopus, TRDizin)

47. Recommendation for treatment of hepatitis C virus infection

Köksal İ., Kaymakoğlu S., Kaymakoğlu S., Tabak F., Akarca U. S., Akbulut A., et al.

Turkish Journal of Gastroenterology , cilt.28, sa.2, 2017 (SCI-Expanded, Scopus, TRDizin)

48. MicroRNA expression profiles in patients with acute Crimean Congo hemorrhagic fever reveal possible adjustments to cellular pathways

Demir Z. C., BAŞTUĞ A., BODUR H., Ergunay K., ÖZKUL A.

Journal of Medical Virology , cilt.89, sa.3, ss.417-422, 2017 (SCI-Expanded, Scopus)

49. Analysis of epidemiology and risk factors for mortality in ventilator-associated pneumonia attacks in intensive care unit patients

But A., Yetkin M. A., Kanyilmaz D., Aslaner H., BAŞTUĞ A., Aypak A., et al.

Turkish Journal of Medical Sciences , cilt.47, sa.3, ss.812-816, 2017 (SCI-Expanded, Scopus, TRDizin)

50. Evalution of geriatric infections in past six years Geriatrik enfeksiyonlarin 6 yillik değerlendirmesi

Özen Y., Tanrici Baştuğ A., ÖNGÜRÜ P., AKINCI E., Yetkin M. A., Ülgen Pepe F., et al.

Turk Geriatri Dergisi , cilt.20, sa.2, ss.82-90, 2017 (SCI-Expanded, SSCI, Scopus, TRDizin)

51. Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe

Ozaras R., Sunbul M., Parlak M., BODUR H., Leblebicioglu H.

Hepatology , cilt.64, sa.5, ss.1825-1827, 2016 (SCI-Expanded, Scopus)

52. Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever

Leblebicioglu H., Sunbul M., BARUT H. Ş., BÜYÜKTUNA S. A., ÖZKURT Z., Yapar D., et al.

Antiviral Research , cilt.133, ss.9-13, 2016 (SCI-Expanded, Scopus)

53. Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever

AKINCI E., BODUR H., Sunbul M., Leblebicioglu H.

Antiviral Research , cilt.132, ss.233-243, 2016 (SCI-Expanded, Scopus)

54. Serratia marcescens bacteremia cases: A pseudo-outbreak experience

MUMCUOĞLU İ., Kanyilmaz D., Yetkin M. A., Cetin F., Ozmen B. B., KARAHAN Z. C., et al.

American Journal of Infection Control , cilt.44, sa.7, ss.852-853, 2016 (SCI-Expanded, Scopus)

55. Discharge criteria for Crimean-Congo haemorrhagic fever in endemic areas

Leblebicioglu H., Sunbul M., BODUR H., Ozaras R., BARUT H. Ş., Buyuktuna S. A., et al.

Journal of Infection , cilt.72, sa.4, ss.500-501, 2016 (SCI-Expanded, Scopus)

56. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: A multicentre retrospective cross-sectional study

Leblebicioglu H., Sunbul M., GÜNER H. R., BODUR H., BULUT C., Duygu F., et al.

Clinical Microbiology and Infection , cilt.22, sa.4, 2016 (SCI-Expanded, Scopus)

57. Mortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study

YILMAZ M., ELALDI N., BALKAN İ. İ., Arslan F., BATIREL A., Baklcl M. Z., et al.

Annals of Clinical Microbiology and Antimicrobials , cilt.15, sa.1, 2016 (SCI-Expanded, Scopus)

58. Crimean-congo hemorrhagic fever: Prognostic factors and the association of leukocyte counts with mortality

BAŞTUĞ A., Kayaaslan B., KAZANCIOĞLU S., Aslaner H., But A., AKINCI E., et al.

Japanese Journal of Infectious Diseases , cilt.69, sa.1, ss.51-55, 2016 (SCI-Expanded, Scopus)

59. A long-term survey of brucellosis: Is there any marker to predict the complicated cases?

KAYAASLAN B., BAŞTUĞ A., Aydin E., AKINCI E., But A., Aslaner H., et al.

Infectious Diseases , cilt.48, sa.3, ss.215-221, 2016 (SCI-Expanded, Scopus)

60. Necrotizing fasciitis due to Streptococcus mitis caused by accidental human bite

BAŞTUĞ A., Kislak S., MUTLU N. M., Akcaboy Z. N., Koksal A., SERTÇELİK A., et al.

Journal of Infection in Developing Countries , cilt.10, sa.1, ss.100-102, 2016 (SCI-Expanded, Scopus)

61. Does the course of laboratory parameters help us to predict the outcome of CCHF?

KAZANCIOĞLU S., AKINCI E., BAŞTUĞ A., KAYAASLAN B., But A., Aslaner H., et al.

Turkish Journal of Medical Sciences , cilt.46, sa.2, ss.328-334, 2016 (SCI-Expanded, Scopus, TRDizin)

62. Investigating the in vitro synergistic activities of several antibiotic combinations against carbapenem-resistant Acinetobacter baumannii isolates

Yavaş S., Yetkın M. A., Kayaaslan B., BAŞTUĞ A., Aslaner H., But A., et al.

Turkish Journal of Medical Sciences , cilt.46, sa.3, ss.892-896, 2016 (SCI-Expanded, Scopus, TRDizin)

63. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies

BAŞTUĞ A., Kayaaslan B., KAZANCIOĞLU S., But A., Aslaner H., AKINCI E., et al.

Journal of Infection in Developing Countries , cilt.9, sa.10, ss.1100-1107, 2015 (SCI-Expanded, Scopus)

64. Consensus report: Preventive measures for Crimean-Congo Hemorrhagic Fever during Eid-al-Adha festival

Leblebicioglu H., Sunbul M., Memish Z. A., Al-Tawfiq J. A., BODUR H., ÖZKUL A., et al.

International Journal of Infectious Diseases , cilt.38, ss.9-15, 2015 (SCI-Expanded, Scopus)

65. Ebola viral disease: What should be done to combat the epidemic in 2014?

BAŞTUĞ A., BODUR H.

Turkish Journal of Medical Sciences , cilt.45, sa.1, 2015 (SCI-Expanded, Scopus, TRDizin)

66. Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

Guclu E., Tuna N., Karabay O., AKHAN S., BODUR H., Ceylan B., et al.

Journal of Infection in Developing Countries , cilt.8, sa.12, ss.1601-1608, 2014 (SCI-Expanded, Scopus)

67. Development and evaluation of a real-time RT-qPCR for detection of crimean-congo hemorrhagic fever virus representing different genotypes

Jääskeläinen A. J., Kallio-Kokko H., ÖZKUL A., BODUR H., Korukruoglu G., Mousavi M., et al.

Vector-Borne and Zoonotic Diseases , cilt.14, sa.12, ss.870-872, 2014 (SCI-Expanded, Scopus)

68. A case of Crimean-Congo hemorrhagic fever complicated with acute pancreatitis

BAŞTUĞ A., Kayaaslan B., But A., Aslaner H., SERTÇELİK A., AKINCI E., et al.

Vector-Borne and Zoonotic Diseases , cilt.14, sa.11, ss.827-829, 2014 (SCI-Expanded, Scopus)

69. Pathogenesis of Crimean-Congo hemorrhagic fever

AKINCI E., BODUR H., Leblebicioglu H.

Vector-Borne and Zoonotic Diseases , cilt.13, sa.7, ss.429-437, 2013 (SCI-Expanded, Scopus)

70. Analysis of 161 adult patients with brucellosis

Kayaaslan B., AKINCI E., BAŞTUĞ A., Eren S. S., ÖNGÜRÜ P., But A., et al.

Turkish Journal of Medical Sciences , cilt.43, sa.2, ss.187-193, 2013 (SCI-Expanded, Scopus, TRDizin)

71. The relationship between the human leukocyte antigen system and Crimean-Congo hemorrhagic fever in the Turkish population

AKINCI E., BODUR H., Muşabak U., Saǧkan R. I.

International Journal of Infectious Diseases , cilt.17, sa.11, 2013 (SCI-Expanded, Scopus)

72. Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens

Yilmaz G. R., BAŞTUĞ A., But A., Yildiz S., Yetkin M. A., Kanyilmaz D., et al.

Journal of Infection and Chemotherapy , cilt.19, sa.1, ss.57-62, 2013 (SCI-Expanded, Scopus)

73. Risk factors for mortality in patients with nosocomial Staphylococcus aureus bacteremia

BAŞTUĞ A., Yilmaz G. R., Kayaaslan B., AKINCI E., BODUR H.

Turkish Journal of Medical Sciences , cilt.42, sa.SUPPL.1, ss.1222-1229, 2012 (SCI-Expanded, Scopus, TRDizin)

74. Two cases of acute hepatitis after a serial knife stabbing

BODUR H., ÖNGÜRÜ P., AKINCI E., Kanyilmaz D., Yetkin A., Ozdemir B., et al.

Diagnostic Microbiology and Infectious Disease , cilt.74, sa.3, ss.311-312, 2012 (SCI-Expanded, Scopus)

75. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever

Leblebicioglu H., BODUR H., Dokuzoguz B., ELALDI N., GÜNER H. R., Koksal I., et al.

Vector-Borne and Zoonotic Diseases , cilt.12, sa.9, ss.805-811, 2012 (SCI-Expanded, Scopus)

76. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey

BODUR H., AKINCI E., Ascioglu S., ÖNGÜRÜ P., UYAR Y.

Emerging Infectious Diseases , cilt.18, sa.4, ss.640-642, 2012 (SCI-Expanded, Scopus)

77. The place and the efficacy of infectious disease consultations in the hospitals

ERDEM H., Kurtaran B., ARUN Ö., Ylmaz H., Çelebi G., Özkaya H. D., et al.

Infectious Diseases in Clinical Practice , cilt.20, sa.2, ss.131-136, 2012 (Scopus)

78. Risk factors for mortality in patients with nosocomial gram-negative bacteremia Nozokomiyal Gram-Negatif Bakteriyemili Hastalarda Mortalite ile İlişkili Risk Faktörleri

Gözel M. G., ERBAY A., BODUR H., Eren S. S., Balaban N.

Turkiye Klinikleri Journal of Medical Sciences , cilt.32, sa.6, ss.1641-1647, 2012 (Scopus)

79. Crimean-congo haemorrhagic fever Kirim kongo kanamali ateşi

ÖNGÜRÜ P., BODUR H.

Ondokuz Mayis Universitesi Tip Dergisi , cilt.29, 2012 (Scopus)

80. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs

ERDEM H., Tekin-Koruk S., Koruk I., Tozlu-Keten D., Ulu-Kilic A., Oncul O., et al.

Annals of Clinical Microbiology and Antimicrobials , cilt.10, 2011 (Scopus)

81. [Evaluation of tularemia cases originated from Central Anatolia, Turkey]. Orta Anadolu Kaynakli Tularemi Olgularinin Deǧerlendirilmesi.

AKINCI E., Ulgen F., KILIÇ S., Yilmaz S., Yildiz S., Ozdemir B., et al.

Mikrobiyoloji bülteni , cilt.45, sa.4, ss.762-764, 2011 (SCI-Expanded, Scopus, TRDizin)

82. Prompt administration of crimean-congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR

Kubar A., Haciomeroglu M., ÖZKUL A., BAĞRIAÇIK E. Ü., AKINCI E., Sener K., et al.

Japanese Journal of Infectious Diseases , cilt.64, sa.5, ss.439-443, 2011 (SCI-Expanded, Scopus)

83. Analysis of 113 hospitalized patients with confirmed 2009 influenza a (H1N1) virus infection 2009 influenza A (H1N1) enfeksiyonu tanısıyla yatırılan 113 hastanın analizi

AKINCI E., Kayaaslan B., Yetkin M. A., Yilmaz S., Aliravci I., Yildiz S., et al.

Turkish Journal of Medical Sciences , cilt.41, sa.3, ss.507-514, 2011 (SCI-Expanded, Scopus, TRDizin)

84. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever

BODUR H., ERBAY A., AKINCI E., ÖNGÜRÜ P., Bayazit N., Eren S. S., et al.

International Journal of Infectious Diseases , cilt.15, sa.1, 2011 (SCI-Expanded, Scopus)

85. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever

BODUR H., AKINCI E., ÖNGÜRÜ P., UYAR Y., Baştürk B., Gözel M. G., et al.

International Journal of Infectious Diseases , cilt.14, sa.8, 2010 (SCI-Expanded, Scopus)

86. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality

ÖNGÜRÜ P., DAĞDAŞ S., BODUR H., Yilmaz M., AKINCI E., Eren S., et al.

Journal of Clinical Laboratory Analysis , cilt.24, sa.3, ss.163-166, 2010 (SCI-Expanded, Scopus)

87. Relative lymphopenia and monocytosis may be considered as a surrogate marker of pandemic influenza a (H1N1)

Coşkun Ö., AVCI İ. Y., Sener K., Yaman H., Ogur R., BODUR H., et al.

Journal of Clinical Virology , cilt.47, sa.4, ss.388-389, 2010 (SCI-Expanded, Scopus)

88. Detection of Crimean-Congo hemorrhagic fever virus genome in saliva and urine

BODUR H., AKINCI E., ÖNGÜRÜ P., ÇARHAN A., UYAR Y., Tanrici A., et al.

International Journal of Infectious Diseases , cilt.14, sa.3, 2010 (SCI-Expanded, Scopus)

89. Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever

Kurt Y. G., Cayci T., ÖNGÜRÜ P., Akgul E. O., Yaman H., Aydin I., et al.

Clinical Chemistry and Laboratory Medicine , cilt.47, sa.12, ss.1543-1547, 2009 (SCI-Expanded, Scopus)

90. Response to Ergonul: Scientific Evidence Versus Personal Beliefs In Crimean-Congo Haemorrhagic Fever Treatment

Ascioglu S., Leblebicioglu H., ELALDI N., BODUR H., VAHABOĞLU H.

Journal of Infection , cilt.59, sa.4, ss.286-289, 2009 (SCI-Expanded, Scopus)

91. Response to Doganci

Ascioglu S., ELALDI N., BODUR H., VAHABOĞLU H., Leblebicioglu H.

Journal of Infection , cilt.59, sa.4, ss.290-291, 2009 (SCI-Expanded, Scopus)

92. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever

AKINCI E., Yilmaz M., BODUR H., ÖNGÜRÜ P., Bayazit F. N., ERBAY A., et al.

International Journal of Infectious Diseases , cilt.13, sa.5, ss.560-563, 2009 (SCI-Expanded, Scopus)

93. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey

ELALDI N., BODUR H., Ascioglu S., Celikbas A., ÖZKURT Z., VAHABOĞLU H., et al.

Journal of Infection , cilt.58, sa.3, ss.238-244, 2009 (SCI-Expanded, Scopus)

94. Listerial rhombencephalitis in an immunocompetent young adult

Kayaaslan B. Ü., AKINCI E., Bilen Ş., Gözel M. G., ERDEM D., Çevik M. A., et al.

International Journal of Infectious Diseases , cilt.13, sa.2, 2009 (SCI-Expanded, Scopus)

95. Brucellosis mimicking enteric fever

ERBAY A., BODUR H., AKINCI E., BAŞTUĞ A., Çevik M. A.

Journal of Infection in Developing Countries , cilt.3, sa.3, ss.239-240, 2009 (Scopus)

96. In vitro activity of tigecycline against Acinetobacter baumannii strains isolated from nosocomial infections

AKINCI E., MUMCUOĞLU İ., ÖNGÜRÜ P., Bayazit F. N., Ersoy Şen S., ERBAY A., et al.

Turkish Journal of Medical Sciences , cilt.38, sa.6, ss.583-586, 2008 (Scopus, TRDizin)

97. Imipenem-resistant Pseudomonas aeruginosa : Risk factors for nosocomial infections

ÖNGÜRÜ P., ERBAY A., BODUR H., Baran G., AKINCI E., Balaban N., et al.

Journal of Korean Medical Science , cilt.23, sa.6, ss.982-987, 2008 (SCI-Expanded, Scopus)

98. A cluster of Klebsiella pneumonia bacteremia in a radiation oncology ward

ERBAY A., Kanyilmaz D., US E., MUMCUOĞLU İ., KARAHAN Z. C., Gozel G., et al.

American Journal of Infection Control , cilt.36, sa.9, ss.678-680, 2008 (SCI-Expanded, Scopus)

99. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever

Çevik M. A., ELALDI N., AKINCI E., ÖNGÜRÜ P., ERBAY A., BUZGAN T., et al.

Journal of Infection , cilt.57, sa.4, ss.350-351, 2008 (SCI-Expanded, Scopus)

100. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality

Çevik M. A., ERBAY A., BODUR H., Gülderen E., BAŞTUĞ A., Kubar A., et al.

International Journal of Infectious Diseases , cilt.12, sa.4, ss.374-379, 2008 (SCI-Expanded, Scopus)

101. High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality

ÖNGÜRÜ P., Akgul E. O., AKINCI E., Yaman H., Kurt Y. G., ERBAY A., et al.

Journal of Infection , cilt.56, sa.5, ss.366-370, 2008 (SCI-Expanded, Scopus)

102. Breastfeeding in crimean-congo haemorrhagic fever

ERBAY A., Çevik M. A., ÖNGÜRÜ P., Gözel G., AKINCI E., Kubar A., et al.

Scandinavian Journal of Infectious Diseases , cilt.40, sa.2, ss.186-188, 2008 (SCI-Expanded, Scopus)

103. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections

Baran G., ERBAY A., BODUR H., ÖNGÜRÜ P., AKINCI E., Balaban N., et al.

International Journal of Infectious Diseases , cilt.12, sa.1, ss.16-21, 2008 (SCI-Expanded, Scopus)

104. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever

Çevik M. A., ERBAY A., BODUR H., Eren S. S., AKINCI E., Şener K., et al.

Clinical Infectious Diseases , cilt.45, sa.7, 2007 (SCI-Expanded, Scopus)

105. Fever of unknown origin: Analysis of 71 consecutive cases

Colpan A., ÖNGÜRÜ P., ERBAY A., AKINCI E., Cevik M. A., Eren S. S., et al.

American Journal of the Medical Sciences , cilt.334, sa.2, ss.92-96, 2007 (SCI-Expanded, Scopus)

106. A complication of brucellosis: Epididymoorchitis

AKINCI E., BODUR H., Çevik M. A., ERBAY A., Eren S. S., Ziraman I., et al.

International Journal of Infectious Diseases , cilt.10, sa.2, ss.171-177, 2006 (SCI-Expanded, Scopus)

107. Glomerulonephritis associating parvovirus B19 infection

ÖNGÜRÜ P., DEDE F., BODUR H., AYLI M. D., AKINCI E., Cevik M., et al.

Renal Failure , cilt.28, sa.1, ss.85-88, 2006 (SCI-Expanded, Scopus)

108. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections

ÖZTOPRAK ÇUVALCI N., Cevik M. A., AKINCI E., Korkmaz M., ERBAY A., Eren S. S., et al.

American Journal of Infection Control , cilt.34, sa.1, ss.1-5, 2006 (SCI-Expanded, Scopus)

109. Characteristics and analysis of risk factors for mortality in infective endocarditis

Leblebicioglu H., Yilmaz H., TAŞOVA Y., ALP MEŞE E., Saba R., Caylan R., et al.

European Journal of Epidemiology , cilt.21, sa.1, ss.25-31, 2006 (SCI-Expanded, Scopus)

110. Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections

AKINCI E., Çolpan A., BODUR H., Balaban N., ERBAY A.

Journal of Hospital Infection , cilt.59, sa.4, ss.317-323, 2005 (Scopus)

111. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: A multicentre study of clinical features and outcome measures

Bakir M., Ugurlu M., Dokuzoguz B., BODUR H., Tasyaran M. A., VAHABOĞLU H.

Journal of Medical Microbiology , cilt.54, sa.4, ss.385-389, 2005 (SCI-Expanded, Scopus)

112. Evaluation of risk factors for mortality in intensive care units: A prospective study from a referral hospital in Turkey

Colpan A., AKINCI E., ERBAY A., Balaban N., BODUR H.

American Journal of Infection Control , cilt.33, sa.1, ss.42-47, 2005 (SCI-Expanded, Scopus)

113. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey

ERBAY A., BODUR H., AKINCI E., Çolpan A.

Journal of Hospital Infection , cilt.59, sa.1, ss.53-61, 2005 (Scopus)

114. Brucellar spondylitis

BODUR H., ERBAY A., Çolpan A., AKINCI E.

Rheumatology International , cilt.24, sa.4, ss.221-226, 2004 (SCI-Expanded, Scopus)

115. Biotypes and antimicrobial susceptibilities of Brucella isolates

BODUR H., Balaban N., AKSARAY S., Yetener V., AKINCI E., Çolpan A., et al.

Scandinavian Journal of Infectious Diseases , cilt.35, sa.5, ss.337-338, 2003 (Scopus)

116. Spontaneous bacterial peritonitis due to Brucella melitensis

ERBAY A., BODUR H., AKINCI E., Çolpan A., Çevik M. A.

Scandinavian Journal of Infectious Diseases , cilt.35, sa.3, ss.196-197, 2003 (Scopus)

117. Neurobrucellosis in an endemic area of brucellosis

BODUR H., ERBAY A., AKINCI E., Çolpan A., Çevik M. A., Balaban N.

Scandinavian Journal of Infectious Diseases , cilt.35, sa.2, ss.94-97, 2003 (Scopus)

118. Evaluation of antibiotic use in a hospital with an antibiotic restriction policy

ERBAY A., Çolpan A., BODUR H., Çevik M. A., Samore M. H., Ergönül Ö.

International Journal of Antimicrobial Agents , cilt.21, sa.4, ss.308-312, 2003 (SCI-Expanded, Scopus)

119. Multifocal tuberculosis presenting with osteoarticular and breast involvement

BODUR H., ERBAY A., BODUR H., Yilmaz O., Kulacoglu S.

Annals of Clinical Microbiology and Antimicrobials , cilt.2, 2003 (Scopus)

120. Arthritis and Osteomyelitis due to Aspergillus fumigatus: A 17 years old boy with chronic granulomatous disease

BODUR H., Ozoran K., Colpan A., Balaban N., TABAK A. Y., Kulacoglu S.

Annals of Clinical Microbiology and Antimicrobials , cilt.2, 2003 (Scopus)

121. Osteoarticular tuberculosis Osteoartiküler tüberküloz.

BODUR H., BODUR H., AKINCI E., Yilmaz O., Borman P., Tanyolaç O., et al.

Tüberküloz ve toraks , cilt.51, sa.4, ss.424-431, 2003 (Scopus, TRDizin)

122. A case of brucellosis presenting with severe thrombocytopenia

AKINCI E., BODUR H., Erbay Ç., Çevik M. A., ERBAY A., Çolpan A.

Turkish Journal of Haematology , cilt.20, sa.1, ss.43-45, 2003 (Scopus)

123. Brucella abortus epididymo-orchitis relapsing in the opposite testis 3 months after antibiotic therapy and development of aspermia [3]

AKINCI E., BODUR H., Erbay Ç., Deveer M.

International Journal of Infectious Diseases , cilt.7, sa.4, ss.290-291, 2003 (Scopus)

124. Venous sinus thrombosis after proteus vulgaris meningitis and concomitant clostridium abscess formation

BODUR H., Colpan A., Gozukucuk R., AKINCI E., Cevik M. A., Balaban N.

Scandinavian Journal of Infectious Diseases , cilt.34, sa.9, ss.694-696, 2002 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim